Providing resources and ideas for therapies and medical developments for Parkinson's disease:


Viruses and Parkinson's Disease:

There are a number of viruses (influenza A, corona viruses, Epstein-Barr virus, varicella zoster, hepatitis C virus, HIV, Japanese encephalitis virus, or West Nile virus) that can lead to Parkinson's like symptoms known as parkinsonism. Studies as far back as to the effects of the Spanish flu epidemic of 1918 showed that survivors had double the chance of developing Parkinson’s disease (PD) later in life. The mechanisms are not well understood and are typically observational.

  • The role of viruses in neurodegenerative and neurobehavioral diseases (2014)
    DOI: 10.2174/187152731307141015122638
  • Occupational risk factors in Parkinson's disease (1999)
    Researchers at the University of British Columbia Hospital Movement Disorders Clinic noticed that teachers and health care workers accounted for an inordinately large proportion of their Parkinson's patients. Researchers hypothesized that an increased exposure to viral respiratory infections, including influenza, predisposed these workers to the development of Parkinson's disease. Employing a case-control design, they found that Parkinson's Disease was associated with being a teacher as well as working in the health care field.
    DOI: 10.1007/BF03404523

COVID-19 virus:

The year 2020 is known for the COVID-19 pandemic. While most survived, many were left with permanent ailments such as loss of smell, difficulty speaking, difficulty texting, slowed movement, tremors, eye movement abnormalities, impaired cognitive performance and impared lung function. It was the neurodegenerative Parkinsonism related hypophonia (slowness of speech), anosmia (loss of sense of smell), tremors and bradykinesia (slowness of movement) that began to forge a COVID-19 associated link to Parkinson's. There are studies linking Sars-CoV-2, the virus that causes COVID-19, with neurological deficits. It is assumed that the pathology is inflammation related and the fact that COVID-19 cases experience high levels of pro-inflammatory cytokines supports the argument. It has also been hypothesized that it is possible that SARS-CoV-2 infection may prompt protein misfolding and aggregation due to altered function including potential mitochondrial dysfunction, loss of proteostasis, autophagy dysfunction, inflammation, and endoplasmic reticulum stress. Other researchers have proposed the "multiple hit hypothesis", by which the combination of toxic stress and an inhibition of neuroprotective responses can lead to neuronal death.

COVID-19/Sars-CoV-2 Therapeutics: COVID-19/Sars-CoV-2 Vaccines: References:

Epstein-Barr virus (EBV) encephalitis:

EBV patients have been observed to have Parkinson's like symptoms in as many as 36% of cases.


Influenza A:

(Hong Kong H3N2 flu of 1968) On histopathological examination, viral antigens were discovered in the neurons of the hippocampus and the dopaminergic neurons of the substantia nigra. The researchers concluded that the substantia nigra could be a major target for neurovirulent forms of influenza A virus in humans as well; possibly causing Parkinson's disease.


Asian Avian Influenza:

(HPA1 H5N1, H7N7) usually contracted direct or close contact with sick or dead poultry that were infected with the virus. A study found that shortly after H5N1 infection in the CNS, the animals appeared transiently bradykinetic with a distinguishable tremor. A 2009 study showed a significant loss of dopaminergic neurons in the substantia nigra pars compacta 60 days after infection.


West Nile Virus:

(WNV encephalitis) acute viral infection of the substantia nigra pars compacta occurs in some patients, resulting in clinical Parkinsonian symptoms including cog-wheel rigidity, bradykinesia, and wide-based gait.

  • Alpha-Synuclein, a Novel Viral Restriction FactorHiding in Plain Sight (2013)
    "Extrapyramidal disorders are frequently observed, and features of Parkinsonism may be seen."
    Paper also presents the hypothesis that alpha-synuclein is part of an anti-virus neuronal immune system and that when "repeated virus-induced changes in a-syn expression in neurons over time may place genetically susceptible individuals at risk for the development of PD". Supporting this argument is that the "olfactory bulb and the GI neurons are common sites of viral neuroinvasion into the CNS" and that an experiment with "a-syn knockout mice exhibited markedly increased virus-induced weight loss, mortality, and caspase 3-dependent neuronal injury".
    DOI: 10.1089/dna.2016.3488
  • Transient parkinsonism in west nile virus encephalitis (2003)
    Case study of two patients
    DOI: 10.1016/S0002-9343(03)00291-2

Hepatitus C:

A study of data from the Taiwan National Health Insurance Research Database revealed that participants with hepatitis C had a 30% greater risk of developing Parkinson’s disease than the controls.


Other Viruses:

herpes simplex 1, Epstein-Barr, varicella zoster, hepatitis C, and influenza A virus can increase the risk of developing Parkinson's disease in the long-term. In 1958 it was reported that 0.3% of H1N1 "Asian Flu" patients reported neurological issues.



Virus - creative commons